Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00185029
What this trial is testing

MR-Lymphography and Lymph Node Staging in Prostate Cancer

Who this might be right for
Prostatic NeoplasmsLymphatic Metastasis
Radboud University Medical Center 396
Not applicableLooking for participantsNCT06917781
What this trial is testing

Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome

Who this might be right for
Prostate Cancer
Institut Claudius Regaud 80
Testing effectiveness (Phase 2)Study completedNCT01834651
What this trial is testing

A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases

Who this might be right for
Prostate Cancer
Edwin Posadas, MD 17
Large-scale testing (Phase 3)Active Not RecruitingNCT04484818
What this trial is testing

Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study

Who this might be right for
Prostate Carcinoma
ECOG-ACRIN Cancer Research Group 27
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Testing effectiveness (Phase 2)Ended earlyNCT04383210
What this trial is testing

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorPancreatic Cancer+14 more
Elevation Oncology 54
Post-approval studies (Phase 4)Study completedNCT00237146
What this trial is testing

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 38
Early research (Phase 1)Ended earlyNCT03861403
What this trial is testing

A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Triple Negative Breast CancerAdvanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer+2 more
Leap Therapeutics, Inc. 10
Large-scale testing (Phase 3)Study completedNCT01438775
What this trial is testing

Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

Who this might be right for
Benign Prostatic Hyperplasia
Nymox Corporation 192
Large-scale testing (Phase 3)Looking for participantsNCT07426094
What this trial is testing

PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer

Who this might be right for
Prostate CancerBrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 600
Early research (Phase 1)WithdrawnNCT06982222
What this trial is testing

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+4 more
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Not Yet RecruitingNCT06660862
What this trial is testing

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Who this might be right for
Prostate Cancer
University of Chicago 80
Testing effectiveness (Phase 2)Study completedNCT07333976
What this trial is testing

O Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic DiseaseChemotherapy Induced Peripheral Neuropathy (CIPN)Neurotoxicity
Tri-Service General Hospital (TSGH) 90
Testing effectiveness (Phase 2)Looking for participantsNCT06150417
What this trial is testing

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Who this might be right for
Prostate CancerMalignant Neoplasm of ProstateSecondary Malignant Neoplasm of Prostate
Case Comprehensive Cancer Center 200
Early research (Phase 1)Study completedNCT00264420
What this trial is testing

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation

Who this might be right for
Bone MetastasesBreast CancerLung Cancer+1 more
The Cleveland Clinic 4
Testing effectiveness (Phase 2)Study completedNCT03362359
What this trial is testing

Ga-68-PSMA-11 in High-risk Prostate Cancer

Who this might be right for
High-risk Prostate CancerProstate CancerProstate Cancer Metastatic+1 more
German Cancer Research Center 173
Testing effectiveness (Phase 2)Study completedNCT00853697
What this trial is testing

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant, Metastatic
Memorial Sloan Kettering Cancer Center 6
Not applicableNot Yet RecruitingNCT07644754
What this trial is testing

Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory Metastases

Who this might be right for
Prostate CancerProstate Cancer Metastatic DiseaseProstate Cancer Metastatic to Bone
University Hospital Tuebingen 27
Not applicableActive Not RecruitingNCT03143322
What this trial is testing

Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases

Who this might be right for
Metastatic Breast CancerMetastatic Lung CancerMetastatic Prostate Cancer+1 more
UNICANCER 168
Not applicableUnknownNCT02123862
What this trial is testing

Cultured Circulating Tumor Cells in Prostate and Other Cancers

Who this might be right for
Prostate Cancer
Oscar Goodman, Jr. 220
Next Page